Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial

BACKGROUND: The pharmacokinetics and metabolism of tacrolimus, an immunosuppressant commonly used to prevent transplant rejection, can differ in specific subpopulations. This analysis examined treatment outcomes and safety of immediate-release tacrolimus (IR-Tac) and LCP-tacrolimus (LCPT) in stable...

Descripción completa

Detalles Bibliográficos
Autores principales: Faravardeh, Arman, Akkina, Sanjeev, Villicana, Rafael, Guerra, Giselle, Moten, Misbah A., Meier-Kriesche, Ulf, Stevens, Daniel R., Patel, Samir J., Bunnapradist, Suphamai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056872/
https://www.ncbi.nlm.nih.gov/pubmed/33859155
http://dx.doi.org/10.12659/AOT.929535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056872/
https://www.ncbi.nlm.nih.gov/pubmed/33859155
http://dx.doi.org/10.12659/AOT.929535

Ejemplares similares